ImageneBio, Inc. (IMA)
NASDAQ: IMA · Real-Time Price · USD
4.550
-0.200 (-4.21%)
Apr 8, 2026, 12:32 PM EDT - Market open
ImageneBio Employees
ImageneBio had 15 employees as of December 31, 2025. The number of employees increased by 5 or 50.00% compared to the previous year.
Employees
15
Change
5
Growth
50.00%
Revenue / Employee
$53,333
Profits / Employee
-$3,493,000
Market Cap
50.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 15 | 5 | 50.00% |
| Mar 31, 2025 | 9 | - | - |
| Dec 31, 2024 | 10 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 142 |
| MindWalk Holdings | 102 |
| ImmuCell | 84 |
| Acrivon Therapeutics | 76 |
| Kezar Life Sciences | 55 |
| OnKure Therapeutics | 45 |
| Entera Bio | 22 |
| Instil Bio | 14 |
IMA News
- 21 days ago - ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update - GlobeNewsWire
- 5 weeks ago - ImageneBio to Participate in Leerink Global Healthcare Conference - GlobeNewsWire
- 2 months ago - ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer - GlobeNewsWire
- 5 months ago - ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team - GlobeNewsWire
- 5 months ago - ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences - GlobeNewsWire
- 9 months ago - Inmagene Biopharmaceuticals Announces Completion of Merger with Ikena Oncology and Concurrent Private Placement of $75 Million - GlobeNewsWire
- 9 months ago - Ikena Oncology and Inmagene Biopharmaceuticals Announce Kristin Yarema, Ph.D., as Chief Executive Officer of Merged Company - GlobeNewsWire